Skip to main content

News

By Dave Muoio | 07:07 am | January 31, 2020
It might just be a matter of time until a phishing attempt finds its mark, meaning that the best strategy for healthcare organizations is to understand their attackers and prepare for the worst, says Healthmap Solutions CISO Kathleen Mullin.
By Dean Koh | 04:08 am | January 31, 2020
Japanese giant Sumitomo Dainippon Pharma and Oxford-headquartered AI-driven drug discovery company Exscientia yesterday announced that they have created a new compound which is in the process of entering human clinical trials in Japan.
By Mike Miliard | 04:15 pm | January 30, 2020
Atefeh Riazi comes to MSK Cancer Center from the United Nations, where she was chief information technology officer.
By Mike Miliard | 03:26 pm | January 30, 2020
The five-year project will focus on enabling faster medical research innovations, protecting against global health crises and improving access to care, the company says.
By Bill Siwicki | 12:44 pm | January 30, 2020
The vendor surveyed provider organizations and found a walk-don’t-run approach to artificial intelligence – administrative, then clinical – unfolding across the industry.
By Mike Miliard | 11:03 am | January 30, 2020
Intermountain's longtime chief information officer will receive the John E. Gall Jr. award at HIMSS20 in Orlando this March.
By Laura Lovett | 04:45 pm | January 29, 2020
Yaya Mbaoua, CEO of The Mbaoua Group, will be speaking at HIMSS20 on how telemedicine could transform Africa’s healthcare.
By Dave Muoio | 03:49 pm | January 29, 2020
A cross-industry research consortium modeled after consumer-focused market research practices is set to present its findings at HIMSS20 in March.
By Bill Siwicki | 01:32 pm | January 29, 2020
Targeting CIOs, CFOs and other health IT leaders, five healthcare financial information systems experts offer best practices for bettering finance IT performance.
By Dave Muoio | 01:30 pm | January 29, 2020
The Silicon Valley EHR vendor received “sponsorship” payments from unnamed pharmaceutical companies so that the latter’s marketing team could influence the design of CDS features, according to the Department of Justice.